Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: JAGSNPHARM and BSE: 507789 (ISIN INE048B01035).
It has a market capitalisation of ₹1,458 crore, a last close of ₹217.67 on 2026-10-19, a one-year return of -0.9%.
Valuation: a price-to-earnings ratio of 32.05x, a price-to-book ratio of 5.28x, a dividend yield of 1.8%.
Profitability: return on equity of 16.7%, return on capital employed of 21.7%, an operating margin of 20.8%.
Growth: sales growth of 6.7% a year over three years, net profit growth of 17.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 68.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,458 |
| Last close | ₹217.67 |
| P/E (TTM) | 32.05x |
| P/B | 5.28x |
| Dividend yield | 1.8% |
| ROE (FY) | 16.7% |
| ROCE (FY) | 21.7% |
| Operating margin (TTM) | 20.8% |
| Sales growth, 3-year CAGR | 6.7% |
| Profit growth, 3-year CAGR | 17.3% |
| Debt / equity | 0.00x |
| Promoter holding | 68.8% |
| 1-year return | -0.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means